AGTR1 and COVID-19: We found a significantly increased baseline AT1R titer in COVID-19 patients (11; IQR, 8–16) compared to controls (10; IQR, 8–15) and IMV controls (6; IQR, 4–12) (p=0.002), but not between controls and IMV patients (Figure 1A).